Karen Firestone
Director · 3 filings · Latest: Aug 31, 2026
Amylyx Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
AMLX | Karen Firestone | Director | Aug 31, 2026 | Option Exercise | $3.41 | 50,000 | $170.3K | 116,900 | |
AMLX | Karen Firestone | Director | May 21, 2026 | Purchase | $13.51 | 3,800 | $51.3K | 66,900 | |